OptiScan Biomedical Completes $20 Million Series E Financing

HAYWARD, Calif.: OptiScan Biomedical Corporation, a developer of an innovative continuous monitoring system for use in the surgical intensive care unit (SICU), today announced the closing of a $20 million Series E financing
error: Content is protected !!